[Edaily Reporter KYUNG GYEYOUNG ] Fila Holdings(081660)published its “Sustainability Report” on the 29th, detailing key sustainability performance metrics and its mid- to long-term strategic direction.
Based on the 2030 Sustainability Roadmap—established in line with the Group’s four core values: △Resilient, △Synergetic, △Empowering, and △Responsible—this report presents implementation results and milestones across all Environmental, Social, and Governance (ESG) areas.
In the environmental sector, the company established targets to reduce direct and indirect greenhouse gas emissions (Scope 1 and 2) by 2030 and expanded the scope of greenhouse gas management in its supply chain (Scope 3). It also increased the share of “FILA Re:Deuce,” its circular economy initiative, to 18%.
In the social sector, the company established a strategic framework for supply chain compliance management. Over the past five years, Misto Korea has carried out corporate social responsibility (CSR) activities totaling 12.8 billion won, while the Misto Group has pursued mutual growth with local communities through initiatives such as brand experience spaces. In the governance sector, the company undertook measures to enhance corporate value, including the cancellation of treasury shares.
A representative from Misto Holdings Corporation stated, “Corporate sustainability is determined not by mere declarations of goals, but by execution and data-driven management capabilities,” adding, “Moving forward, we will continue to use our 2030 Sustainable Management Roadmap as our compass to continuously enhance our response to climate change, supply chain management, and responsible governance, thereby simultaneously increasing long-term corporate value and stakeholder trust.”
The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…